Skip to content

Med-stat.info

The latest health news

  • Coronavirus
  • Biotech
  • Health Tech
  • First Opinion
  • In the Lab
  • Pharma
Main Menu

Tag: drug development

First Opinion / Pharma

Opinion: Stop blaming Biogen for putting profit at the expense of patients. Blame the systems that enabled it

17.01.2023

Two congressional committees recently released damning results of an 18-month investigation into the Food and Drug Administration’s approval of Biogen’s controversial Alzheimer’s drug, Aduhelm. The systems that enabled Biogen’s actions, …

Read More
First Opinion / Pharma

Opinion: Democratizing drug development will be a win for all

12.01.2023

In 1992, the film Lorenzo’s Oil celebrated the true story of two parents who, despite their lack of scientific training, gathered the know-how and support they needed to develop a …

Read More
Biotech / First Opinion

Opinion: Is the golden age of biotech stocks over?

10.01.2023

Much of the last decade felt like the golden age of biotechnology investing. Money — lots of money — was poured into new gene therapies that replaced defective genes with …

Read More
First Opinion

Opinion: The Aduhelm Operetta: ‘I’ve got a little list’

01.01.2023

The Congressional report on the FDA’s approval of Aduhelm makes some good points. As regulatory science advances, so too must the FDA’s administrative procedures. But this report mustn’t be seen …

Read More
Health

A letter from the executive editor: The Aduhelm Files

29.12.2022

Dear Reader, From STAT’s first investigations in June 2021 revealing why the FDA gave the go-ahead for a marginally effective Alzheimer’s drug manufactured by Biogen, we have relentlessly stayed on …

Read More
First Opinion

Opinion: Lessons learned from the deadly combination of sepsis and Covid-19

22.12.2022

Sepsis, a deadly overreaction of the immune system to infection, has befuddled clinicians and researchers for decades. Covid-19 made things worse. The early signs and symptoms of sepsis mimic those …

Read More
First Opinion

Opinion: Breakthrough Therapies Act: Good idea, wrong solution

02.12.2022

The Breakthrough Therapies Act, recently proposed by Senators Rand Paul (R-Ky.) and Cory Booker (D-N.J.) as a way to expand access for therapeutic purposes to potentially beneficial but highly regulated …

Read More
Biotech / In the Lab / Pharma

On the long road to treating Huntington’s genetic stutter, scientists return to overlooked clues

30.11.2022

In the spring of 1981, a geneticist from Indianapolis and a neurologist from Chicago got in a car and for three days they crisscrossed the yellowing cornfields of Iowa. Every …

Read More
Biotech / Health

After decades of setbacks, scientists make strides toward the holy grail of male birth control

16.11.2022

The headlines spelled the end of a short-lived scientific hope: “Male birth control study nixed after men can’t handle side effects women face daily,” USA Today announced. “Men Back Out …

Read More

Posts navigation

1 2 … 12 Next
Copyright © Med-stat.info
  • Terms of Service
  • Privacy Policy